Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Systematic Review Article

A Systematic Review of the COVID Vaccine's Impact on the Nervous System

In Press, (this is not the final "Version of Record"). Available online 24 January, 2024
Author(s): Viswarupachari Tanguturi Yella, Sumit Pareek, Bhumika Meena, K.S.B.S. Krishna Sasanka, Pugazhenthan Thangaraju and Sree Sudha T Y*
Published on: 24 January, 2024

DOI: 10.2174/0115748863273931231121072231

Price: $95

conference banner
Abstract

Aims & Objectives: The objective of this study was to conduct a systematic review of research pertaining to the COVID-19 vaccine and its association with neurological complications.

Method: We performed a comprehensive search of the literature using Google Scholar, PubMed, and NCBI databases from December 2021 to December 2022. For Google Scholar, PubMed, and NCBI databases we used the following key search terms: “neurological adverse effects”, “COVID-19 vaccination”, “SARS-CoV-2”, CNS complications, and CNS adverse effects. Two reviewer authors individually searched and assessed the titles and abstracts of all articles. The third reviewer resolved the disagreement between them. Data were documented regarding title, study location, type of study, type of COVID-19 vaccine, type of neurological complications/adverse effects, and sample size.

Results: From our findings, it is confirmed that these neurological complications like GuillainBarre syndrome (23.6%), Neuromyelitis Optica spectrum disorder (5.5%), Neuropathy (6.9%), Transverse Myelitis (8.3%) and Acute disseminated Encephalomyelitis (4.1%) are majorly affected in most of the people. The increase in risks associated with SARS-CoV-2 infection far outweighs any previously reported associations with vaccination.

Conclusion: We found no safety signal was observed between COVID-19 vaccines and the immune-mediated neurological events. Before assuming a causal relationship, the side effects of the COVID-19 vaccine should first be carefully examined to rule out known associated factors. Symptom onset was within two weeks of vaccination in the majority of cases; as such, this seems to be a high-risk period warranting vigilance.

Keywords: Neurological adverse effects, COVID-19 vaccination, SARS-CoV-2, CNS complications, CNS adverse effects, Transverse Myelitis, Guillain-Barre syndrome, Acute disseminated Encephalomyelitis, Neuropathy, Pfizer, AstraZeneca, Johnson & Johnson, Moderna, Sinovac, Sinopharm, Sputnik, and Covaxin


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy